Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

For decades, the spread of multidrug-resistant (MDR) Acinetobacter baumannii has been rampant in critically ill, hospitalized patients. Traditional antibiotic therapies against this pathogen have been failing, leading to rising concerns over management options for patients. Two new antibiotics, erav...

Descripción completa

Detalles Bibliográficos
Autores principales: Deolankar, Manas S., Carr, Rachel A., Fliorent, Rebecca, Roh, Sean, Fraimow, Henry, Carabetta, Valerie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598263/
https://www.ncbi.nlm.nih.gov/pubmed/36289956
http://dx.doi.org/10.3390/antibiotics11101298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598263/
https://www.ncbi.nlm.nih.gov/pubmed/36289956
http://dx.doi.org/10.3390/antibiotics11101298

Ejemplares similares